Dexcom Ventures
Overview
Dexcom Ventures is the corporate venture capital arm of Dexcom, launched in 2021. It focuses on investment opportunities in sensing technology, data analytics, remote patient monitoring, and population health, aiming to advance better outcomes in healthcare . The fund supports independent initiatives in glucose sensing technologies and adjacent fields of metabolic monitoring . Dexcom Ventures seeks to drive the next wave of health innovations via a world-class venture capital platform .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Epitel, Inc. | Feb 2022 | Series A | Co-investor |
| MedCrypt | Jan 2023 | Series B Extension | Lead |
| Signos | Oct 2023 | Series B | Co-investor |
| myBiometry | Nov 2024 | Seed | Lead |
| Nutromics | Sep 2022 | Seed | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Dexcom Ventures based?
Dexcom Ventures is headquartered in San Diego, California, United States.
When was Dexcom Ventures founded?
Dexcom Ventures was founded in 2021.
How many portfolio companies does Dexcom Ventures have?
Dexcom Ventures has 7 portfolio companies in Caplight's dataset.
What are some companies in Dexcom Ventures's portfolio?
Portfolio companies visible on Caplight include Epitel, Inc., MedCrypt, Signos, myBiometry, Nutromics.
What was Dexcom Ventures's most recent investment shown here?
Dexcom Ventures's most recent investment in this portfolio sample was in myBiometry in 2024.
What sectors does Dexcom Ventures focus on?
Dexcom Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Cybersecurity, Healthcare & Life Sciences, Enterprise Software, Consumer & Commerce, Enterprise Software.
What company stages does Dexcom Ventures focus on?
Dexcom Ventures typically invests at the Mid stage.
What is Dexcom Ventures's AUM?
Dexcom Ventures's assets under management are estimated between $0.0 and $50.0M.